However, considering the association between elevated CRP levels and increased CAD, independent of hyperlipidemia, and the ability of statin therapy to reduce CRP levels regardless of its effect on lipid levels, it is plausible that statins may prevent ACS in individuals with elevated CRP levels. The gene discussed is CRP; the disease is hyperlipidemia.